FPR2 inhibition significantly prevents cell proliferation and the malignant phenotype, suggesting the potential role of FPR2 signalling and, in turn, of phosphorylated proteins as drug targets in lung cancer epithelial cells16. This evidence concerns the gene FPR2 and lung carcinoma.